Trying this at home: Bioxcel steps closer to an sNDA for Igalmi – VIDEO

The BioWorld Insider Podcast
27/08/2025 9 min Temporada 1 Episodio 52
Trying this at home: Bioxcel steps closer to an sNDA for Igalmi – VIDEO

Listen "Trying this at home: Bioxcel steps closer to an sNDA for Igalmi – VIDEO"

Descargar episodio Ver en sitio original

Episode Synopsis

Bioxcel Therapeutics Inc.’s phase III results in bipolar disorders or schizophrenia could bring Igalmi (BXCL-501) out of the clinic and into patients' homes for easier treatment. Vimal Mehta, Bioxcel CEO, talks about the potential with Lee Landenberger in the latest BioWorld Insider podcast.

More episodes of the podcast The BioWorld Insider Podcast

Trying this at home: Bioxcel steps closer to an sNDA for Igalmi – AUDIO 29/08/2025
The importance of balancing AI and people in drug development 27/05/2025
Two CEOs discuss bracing for tariffs, NIH grant cuts and gifting China biopharma leadership position 23/04/2025
As biopharma investments stumble, med tech surges 30/03/2025
Mega money well spent? Mammoth mergers fall short of the dream 24/02/2025
Healing the health divide for women 22/11/2024
Modifi gets creative on the rocky road to a multibillion-dollar buyout 13/11/2024
A quantum leap into the future of drug development 17/10/2024
Gene and cell therapies will propel innovation, says Astellas CCO 07/10/2024
Capricor’s CEO pursues a BLA and talks rare disease 27/09/2024
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA